Medical Products
![banner](/sites/default/files/styles/case_study_thumbnail/public/2021-04/205.png?itok=YTu8Ggp6)
Customer & Market Due Diligence Of Neuroscience Research Lab Instrument Manufacturer: Establishing Growth Outlook And Competitive Positioning
Conducted customer & market due diligence to establish target’s growth outlook and line expansion/acquisition opportunities. To this end, Gotham: established neuroscience research growth outlook; conducted interviews with academic and non-profit research laboratories; built robust view of products and competition via a bottom-up effort; built a market sizing model based on ~100K NIH grants; and developed a software monetization strategy. Gotham’s robust and fact-based assessment provided our client confidence in moving forward with the acquisition.
Show Details![banner](/sites/default/files/styles/case_study_thumbnail/public/2018-10/110.jpg?itok=hM8nOnxU)
Delivery Performance Turnaround at Precision Medical Device Component Manufacturer: Rapid Backlog Reduction and Sustainable Delivery System
Rapidly reduced backlog and created a robust delivery system. Backlog reduction effort included rolling out prioritized schedule, developing and implementing debottlenecking strategies, creating a cross-functional team resolving issues that were stopping scheduled jobs. Robust delivery system initiatives included: 1) turning on the planning and scheduling functionality of the ERP/cleaning up system data and parameters, developing SOPs for data entry, training the workforce on the SOP; 2) improving the accuracy of time estimates by revamping engineering process; and 3) reducing quality defects by 20%. Within 3 months, on-time performance improved from 59% to 93% while lead time shrunk from 13-16 weeks to 10 weeks, with backlog reduced in half.
Show Details![banner](/sites/default/files/styles/case_study_thumbnail/public/2021-01/204.jpg?itok=5AFe9kw7)
Customer & Market Due Diligence Of Clinical Trial Packaging Manufacturer: Establishing Growth Outlook And Competitive Positioning
Conducted a 3-week customer & market due diligence to: establish market size/growth outlook; understand insourcing risks and substitution threats; and establish the target's reputation/competitive positioning. To this end, Gotham: conducted 26 interviews with clinical trial sponsors (pharmaceutical and biotech companies), CRO, CMO, and CPO companies; assessed substitution threats; identified and profiled key clinical trial packaging competitors; established clinical trial growth outlook in light of COVID-19; and built a bottom-up market sizing model based on individual clinical trial level details. Our client was able to move forward on its bid with confidence and successfully closed the transaction.
Show Details![banner](/sites/default/files/styles/case_study_thumbnail/public/2018-09/071.jpg?itok=4hWoyWea)
Operational Due Diligence of Medical Products Ecommerce Retailer: Deciphering and Controlling Outsourced Distribution Cost Structures
Modeled the warehouse, outbound freight, inventory, and inbound freight cost structures of a 3rd-party logistics company in the midst of contract renegotiations and a move to a new warehouse. Identified $1.3MM in financial exposure and weaknesses in contracted outbound freight pricing which drove operational instability, resulting in a 22% reduction in the acquisition price.
Show Details![banner](/sites/default/files/styles/case_study_thumbnail/public/2018-09/case066.jpg?itok=T8IdB6Lf)
Proactive Investment Strategy for New Private Equity Fund: Identifying Promising Niche Industries to Create an Investment Framework for Inclusion in the PPM
Worked with this mid-market PE firm to translate the broad investment criteria for the new fund into specific quantitative and qualitative criteria targeting promising industries. Conducted analytical research to identify 7 focus industries, and assessed trends/dynamics and developed benchmarks for each of the industries to be used in deal evaluation. PE firm successfully raised the new fund and closed 3 deals within 2 years in the targeted industry niches.
Show Details![banner](/sites/default/files/styles/case_study_thumbnail/public/2018-09/024.jpg?itok=Z22b2Kvm)
Marketing Effectiveness for Multi-Billion-Dollar Drug Product: Understanding and Analyzing the Impact of Generic Entry and Developing Financial and Manufacturing Plan to Optimize Marketing Spend
Assessed generic competitive landscape for $2B drug, including profiling costs and lead time for generic market entry, generating likely penetration scenarios (pricing and market share), and quantifying financial impact of generic launch sequences across 7 major worldwide markets. The study resulted in creation of a re-usable proactive planning tool for modeling the effects of generic product entry into the market.
Show Details